Studies on the Safety and Efficacy of Pyrotinib in the Treatment of HER2- Positive Advanced Solid Tumors Excluding Breast Cancer

Overview of attention for article published in Cancer Management and Research, December 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 13 publications that cite this research output.

13

The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.

HER2+ advanced gastric cancer: Current state and opportunities (Review)

Article in International Journal of Oncology (February 2024)

Efficacy and safety of a pyrotinib-based regimen in non-small cell lung cancer patients harboring HER2 alterations: A real-world retrospective study.

Article in Journal of Cancer Research and Therapeutics (December 2023)

HER2-positive advanced biliary tract cancer responds to second-line pyrotinib therapy: a case report

Article in Anti-Cancer Drugs (November 2023)